Skip to main content
Top
Published in: Journal of Parasitic Diseases 4/2016

01-12-2016 | Original Article

Detection of Fasciola hepatica and Fasciola gigantica common and uncommon antigens, using rabbit hyper immune serum raised against their excretory–secretory and somatic antigens

Authors: S. Abdolahi Khabisi, B. Sarkari

Published in: Journal of Parasitic Diseases | Issue 4/2016

Login to get access

Abstract

Fasciolosis is an important neglected helminth disease caused by two liver flukes, Fasciola hepatica and Fasciola gigantica. The two species of Fasciola are usually different in their morphological and molecular features. They have also common and uncommon antigens in both their somatic and excretory secretory metabolites. In this study, we compared somatic and excretory–secretory (ES) antigens of F. hepatica and F. gigantica, by using rabbit hyper immune serum raised against these antigens. Adult worms were collected from bile ducts of infected animals and species of the fluke was confirmed by RFLP-PCR. ES and somatic antigens of both species were prepared. Rabbits were subcutaneously immunized with either ES or somatic antigens to produce antibodies against these antigens. SDS-PAGE pattern of F. hepatica and F. gigantica somatic antigens was similar and both of them revealed 30 protein bands, ranging from 18 to 180 kDa. In contrast, SDS-PAGE pattern of ES antigen of the two species was different. While protein bands with molecular weight of 18, 27, 29, 48, and 62 kDa were common in both species, bands of 19, 45, 55 and 58 kDa were only noticed in F. hepatica ES antigen. Rabbit polyclonal antibodies, raised against F. hepatica and F. gigantica ES antigen, reacted with main five protein bands, 25, 27, 29, 62 and 67 kDa and polyclonal antibodies raised against somatic antigens of both species reacted with three protein bands, 25, 27 and 72 kDa. Thus, the 25, 27 and 29 kDa protein bands may serve as immunodominant antigens, which might be considered for serodiagnosis of fasciolosis. Moreover, bands of 62 and 67 kDa in ES antigen and 72 kDa in somatic antigens of both species were immunodominant and might be suitable candidate for development of serological assays for diagnosis of fasciolosis.
Literature
go back to reference Allam AF, El Sayed I, Helmy MH (2002) Molecular and immunological characterization of Fasciola species. Br J Biomed Sci 59:191–195CrossRef Allam AF, El Sayed I, Helmy MH (2002) Molecular and immunological characterization of Fasciola species. Br J Biomed Sci 59:191–195CrossRef
go back to reference Attallah AM, Karawia EA, Ismail H, Tabll AA, Nawar AA, Ragab WA, Abdel Aziz MM, El-Dosoky I (2002) Identification and characterization of a 26- to 28-kDa circulating antigen of Fasciola gigantica. Ann Trop Med Parasitol 96:271–282CrossRefPubMed Attallah AM, Karawia EA, Ismail H, Tabll AA, Nawar AA, Ragab WA, Abdel Aziz MM, El-Dosoky I (2002) Identification and characterization of a 26- to 28-kDa circulating antigen of Fasciola gigantica. Ann Trop Med Parasitol 96:271–282CrossRefPubMed
go back to reference Dalimi A, Hadighi R, Madani R (2004) Partially purified fraction (PPF) antigen from adult Fasciola gigantica for the serodiagnosis of human fascioliasis using Dot-ELISA technique. Ann Saudi Med 24:18–20PubMed Dalimi A, Hadighi R, Madani R (2004) Partially purified fraction (PPF) antigen from adult Fasciola gigantica for the serodiagnosis of human fascioliasis using Dot-ELISA technique. Ann Saudi Med 24:18–20PubMed
go back to reference De Almeida MA, Ferreira MB, Planchart S, Terashima A, Maco V, Marcos L, Gotuzzo E, Sánchez E, Náquira C, Scorza JV, Incani RN (2007) Preliminary antigenic characterizations of an adult worm vomit preparation of Fasciola hepatica by infected human sera. Rev Inst Med Trop Sao Paulo 49:31–35CrossRefPubMed De Almeida MA, Ferreira MB, Planchart S, Terashima A, Maco V, Marcos L, Gotuzzo E, Sánchez E, Náquira C, Scorza JV, Incani RN (2007) Preliminary antigenic characterizations of an adult worm vomit preparation of Fasciola hepatica by infected human sera. Rev Inst Med Trop Sao Paulo 49:31–35CrossRefPubMed
go back to reference Dixit AK, Dixit P, Sharma RL (2008) Immunodiagnostic/protective role of cathepsin L cysteine proteinases secreted by Fasciola species. Vet Parasitol 154:177–184CrossRefPubMed Dixit AK, Dixit P, Sharma RL (2008) Immunodiagnostic/protective role of cathepsin L cysteine proteinases secreted by Fasciola species. Vet Parasitol 154:177–184CrossRefPubMed
go back to reference Espinoza JR, Maco V, Marcos L, Saez S, Neyra V, Terashima A, Samalvides F, Gotuzzo E, Chavarry E, Huaman MC, Bargues MD, Valero MA, Mas-Coma S (2007) Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans. Am J Trop Med Hyg 76:977–982PubMed Espinoza JR, Maco V, Marcos L, Saez S, Neyra V, Terashima A, Samalvides F, Gotuzzo E, Chavarry E, Huaman MC, Bargues MD, Valero MA, Mas-Coma S (2007) Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans. Am J Trop Med Hyg 76:977–982PubMed
go back to reference Gonence B, Sarimehmetoglu H (2004) Comparison of crude and excretory/secretory antigens for the diagnosis of Fasciola hepatica in sheep by western blotting. Turk J Vet Anim Sci 28:943–949 Gonence B, Sarimehmetoglu H (2004) Comparison of crude and excretory/secretory antigens for the diagnosis of Fasciola hepatica in sheep by western blotting. Turk J Vet Anim Sci 28:943–949
go back to reference Hammami H, Ayadi A, Camus D, Dutoit E (1997) Diagnostic value of the demonstration of specific antigen of Fasciola hepatica by western blot technique. J Parasitol 4:291–295 Hammami H, Ayadi A, Camus D, Dutoit E (1997) Diagnostic value of the demonstration of specific antigen of Fasciola hepatica by western blot technique. J Parasitol 4:291–295
go back to reference Hotez PJ, Savioli L, Fenwick A (2012) Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis 6:e1475CrossRefPubMedPubMedCentral Hotez PJ, Savioli L, Fenwick A (2012) Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis 6:e1475CrossRefPubMedPubMedCentral
go back to reference Intapan PM, Maleewong W, Wongkham C, Tomanakarn K, Ieamviteevanich K, Pipitgool V, Sukolapong V (1998) Excretory–secretory antigenic components of adult Fasciola gigantica recognized by infected human sera. Southeast Asian J Trop Med Public Health 29:579–583PubMed Intapan PM, Maleewong W, Wongkham C, Tomanakarn K, Ieamviteevanich K, Pipitgool V, Sukolapong V (1998) Excretory–secretory antigenic components of adult Fasciola gigantica recognized by infected human sera. Southeast Asian J Trop Med Public Health 29:579–583PubMed
go back to reference Kamel HH, Saad GA, Sarhan RM (2013) Dot-blot immunoassay of Fasciola gigantic infection using 27 kDa and adult worm regurge antigens in Egyptian patients. Korean J Parasitol 51:177–182CrossRefPubMedPubMedCentral Kamel HH, Saad GA, Sarhan RM (2013) Dot-blot immunoassay of Fasciola gigantic infection using 27 kDa and adult worm regurge antigens in Egyptian patients. Korean J Parasitol 51:177–182CrossRefPubMedPubMedCentral
go back to reference Maleewong W, Intapan PM, Tomanakarn K, Wongkham C (1997) Antigenic components of somatic extract from adult Fasciola gigantica recognized by infected human sera. Asian Pac J Allergy Immunol 15:213–218PubMed Maleewong W, Intapan PM, Tomanakarn K, Wongkham C (1997) Antigenic components of somatic extract from adult Fasciola gigantica recognized by infected human sera. Asian Pac J Allergy Immunol 15:213–218PubMed
go back to reference Mas-Coma S, Valero MA, Bargues MD (2009) Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv Parasitol 69:41–146CrossRefPubMed Mas-Coma S, Valero MA, Bargues MD (2009) Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv Parasitol 69:41–146CrossRefPubMed
go back to reference Meshgi B, Eslami A, Hemmatzadeh F (2008) Determination of somatic and excretory–secretory antigens of Fasciola hepatica and Fasciola gigantica using SDS-PAGE. Iran J Vet Res 9:77–80 Meshgi B, Eslami A, Hemmatzadeh F (2008) Determination of somatic and excretory–secretory antigens of Fasciola hepatica and Fasciola gigantica using SDS-PAGE. Iran J Vet Res 9:77–80
go back to reference Moghaddam AS, Massoud J, Mahmoodi M, Mahvi AH, Periago MV, Artigas P, Fuentes MV, Bargues MD, Mas-Coma S (2004) Human and animal fascioliasis in Mazandaran province, Northern Iran. Parasitol Res 94:61–69CrossRefPubMed Moghaddam AS, Massoud J, Mahmoodi M, Mahvi AH, Periago MV, Artigas P, Fuentes MV, Bargues MD, Mas-Coma S (2004) Human and animal fascioliasis in Mazandaran province, Northern Iran. Parasitol Res 94:61–69CrossRefPubMed
go back to reference Morales A, Espino AM (2012) Evaluation and characterization of Fasciola hepatica tegument protein extract for serodiagnosis of human fascioliasis. Clin Vaccine Immunol 19:1870–1878CrossRefPubMedPubMedCentral Morales A, Espino AM (2012) Evaluation and characterization of Fasciola hepatica tegument protein extract for serodiagnosis of human fascioliasis. Clin Vaccine Immunol 19:1870–1878CrossRefPubMedPubMedCentral
go back to reference O’Neill SM, Parkinson M, Dowd AJ, Strauss W, Angles R, Dalton JP (1999) Immunodiagnosis of human fascioliasis using recombinant Fasciola hepatica cathepsin L1 cysteine proteinase. Am J Trop Med Hyg 60:749–751PubMed O’Neill SM, Parkinson M, Dowd AJ, Strauss W, Angles R, Dalton JP (1999) Immunodiagnosis of human fascioliasis using recombinant Fasciola hepatica cathepsin L1 cysteine proteinase. Am J Trop Med Hyg 60:749–751PubMed
go back to reference Rokni MB (2008) The present status of human helminthic diseases in Iran. Ann Trop Med Parasitol 102:283–295CrossRefPubMed Rokni MB (2008) The present status of human helminthic diseases in Iran. Ann Trop Med Parasitol 102:283–295CrossRefPubMed
go back to reference Rokni MB, Massoud J, O’Neill SM, Parkinson M, Dalton JP (2002) Diagnosis of human fasciolosis in the Gilan province of Northern Iran: application of cathepsin L-ELISA. Diagn Microbiol Infect Dis 44:175–179CrossRefPubMed Rokni MB, Massoud J, O’Neill SM, Parkinson M, Dalton JP (2002) Diagnosis of human fasciolosis in the Gilan province of Northern Iran: application of cathepsin L-ELISA. Diagn Microbiol Infect Dis 44:175–179CrossRefPubMed
go back to reference Rokni MB, Massoud J, Hanilo A (2003) Comparison of adult somatic and cysteine proteinase antigens of Fasciola gigantica in enzyme linked immunosorbent assay for serodiagnosis of human fasciolosis. Acta Trop 88:69–75CrossRefPubMed Rokni MB, Massoud J, Hanilo A (2003) Comparison of adult somatic and cysteine proteinase antigens of Fasciola gigantica in enzyme linked immunosorbent assay for serodiagnosis of human fasciolosis. Acta Trop 88:69–75CrossRefPubMed
go back to reference Rokni MB, Baghernejad A, Mohebali M, Kia EB (2004) Enzyme-linked immunotransfer blot analysis of somatic and excretory–secretory antigens of Fasciola hepatica in diagnosis of human fasciolosis. Iranian J Publ Health 33:8–13 Rokni MB, Baghernejad A, Mohebali M, Kia EB (2004) Enzyme-linked immunotransfer blot analysis of somatic and excretory–secretory antigens of Fasciola hepatica in diagnosis of human fasciolosis. Iranian J Publ Health 33:8–13
go back to reference Sampaio Silva M, Correia da Costa J, Viana da Costa AM, Pires MA, Lopes SA, Am Castro, Monjour L (1996) Antigenic components of excretory secretory products of adult Fasciola hepatica recognized in human infection. J Trop Med Hyg 54:146–148 Sampaio Silva M, Correia da Costa J, Viana da Costa AM, Pires MA, Lopes SA, Am Castro, Monjour L (1996) Antigenic components of excretory secretory products of adult Fasciola hepatica recognized in human infection. J Trop Med Hyg 54:146–148
go back to reference Santiago N, Hillyer GV (1988) Antibody profiles by EITB and ELISA of cattle and sheep infected with Fasciola hepatica. J Parasitol 74:810–818CrossRefPubMed Santiago N, Hillyer GV (1988) Antibody profiles by EITB and ELISA of cattle and sheep infected with Fasciola hepatica. J Parasitol 74:810–818CrossRefPubMed
go back to reference Sarkari B, Ghobakhloo N, Moshfea A, Eilami O (2012) Seroprevalence of human fasciolosis in a new-emerging focus of fasciolosis in Yasuj district, southwest of Iran. Iran J Parasitol 7:15–20PubMedPubMedCentral Sarkari B, Ghobakhloo N, Moshfea A, Eilami O (2012) Seroprevalence of human fasciolosis in a new-emerging focus of fasciolosis in Yasuj district, southwest of Iran. Iran J Parasitol 7:15–20PubMedPubMedCentral
go back to reference Shafiei R, Sarkari B, Moshfe A (2013) Consistent PCR-RFLP assay based on ITS-2 ribosomal DNA for differentiation of Fasciola species. Iran J Basic Med Sci 16:1266–1269PubMedPubMedCentral Shafiei R, Sarkari B, Moshfe A (2013) Consistent PCR-RFLP assay based on ITS-2 ribosomal DNA for differentiation of Fasciola species. Iran J Basic Med Sci 16:1266–1269PubMedPubMedCentral
go back to reference Shafiei R, Sarkari B, Sadjjadi SM, Mowlavi GR, Moshfe A (2014) Molecular and morphological characterization of Fasciola spp. isolated from different host species in a newly emerging focus of human fascioliasis in Iran. Vet Med Int 2014:405740CrossRefPubMedPubMedCentral Shafiei R, Sarkari B, Sadjjadi SM, Mowlavi GR, Moshfe A (2014) Molecular and morphological characterization of Fasciola spp. isolated from different host species in a newly emerging focus of human fascioliasis in Iran. Vet Med Int 2014:405740CrossRefPubMedPubMedCentral
go back to reference Shafiei R, Sarkari B, Sadjjadi SM (2015) Performance of a 27 kDa Fasciola hepatica antigen in the diagnosis of human fascioliasis. J Lab Physicians 7:17–20CrossRefPubMedPubMedCentral Shafiei R, Sarkari B, Sadjjadi SM (2015) Performance of a 27 kDa Fasciola hepatica antigen in the diagnosis of human fascioliasis. J Lab Physicians 7:17–20CrossRefPubMedPubMedCentral
go back to reference Soliman MF (2008) Epidemiological review of human and animal fascioliasis in Egypt. J Infect Dev Ctries 2:182–189CrossRefPubMed Soliman MF (2008) Epidemiological review of human and animal fascioliasis in Egypt. J Infect Dev Ctries 2:182–189CrossRefPubMed
go back to reference Velusamy R, Singh BP, Ghosh S, Chandra D, Raina OK, Gupta SC, Jayraw AK (2006) Prepatent detection of Fasciola gigantica infection in bovine calves using metacercarial antigen. Indian J Exp Biol 44:749–753PubMed Velusamy R, Singh BP, Ghosh S, Chandra D, Raina OK, Gupta SC, Jayraw AK (2006) Prepatent detection of Fasciola gigantica infection in bovine calves using metacercarial antigen. Indian J Exp Biol 44:749–753PubMed
go back to reference WHO (2010) The “neglected” worms. Action against worms. December 2007, Issue 10 WHO (2010) The “neglected” worms. Action against worms. December 2007, Issue 10
go back to reference Yokananth S, Ghosh S, Gupta SC, Suresh MG, Saravanan D (2005) Characterization of specific and cross-reacting antigens of Fasciola gigantica by immunoblotting. Parasitol Res 97:41–48CrossRefPubMed Yokananth S, Ghosh S, Gupta SC, Suresh MG, Saravanan D (2005) Characterization of specific and cross-reacting antigens of Fasciola gigantica by immunoblotting. Parasitol Res 97:41–48CrossRefPubMed
Metadata
Title
Detection of Fasciola hepatica and Fasciola gigantica common and uncommon antigens, using rabbit hyper immune serum raised against their excretory–secretory and somatic antigens
Authors
S. Abdolahi Khabisi
B. Sarkari
Publication date
01-12-2016
Publisher
Springer India
Published in
Journal of Parasitic Diseases / Issue 4/2016
Print ISSN: 0971-7196
Electronic ISSN: 0975-0703
DOI
https://doi.org/10.1007/s12639-015-0726-5

Other articles of this Issue 4/2016

Journal of Parasitic Diseases 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.